Balyasny Asset Management »

Benitec Biopharma shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.8M 652k 13.47
2025-06-30 $0 0 0.00
2025-03-31 $37k 2.8k 13.01

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Franklin Resources
Adage Capital Partners GP
RA Capital Management
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Balyasny Asset Management
Millennium Management
Geode Capital Management
AWM Investment Company

View all funds holding Benitec Biopharma